Anti-Cdk4 antibody [EPR4513-32-7]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(1 Review)
|
(216 Publications)
Anti-Cdk4 antibody [EPR4513-32-7] (ab108357) is a rabbit monoclonal antibody detecting Cdk4 in Western Blot, Flow Cytometry (Intra), IHC-P, ICC/IF. Suitable for Human.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 160 publications
View Alternative Names
Cyclin-dependent kinase 4, Cell division protein kinase 4, PSK-J3, CDK4
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervix carcinoma tissue labeling Cdk4 with purified ab108357 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer (pH 9). ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L), was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
ab108357 staining CDK4in the human cell line MCF7 (human breast adenocarcinoma cell line) by intracellular flow cytometry. Cells were fixed with 4% paraformaldehyde, permeabilized with 90% methanol and the sample was incubated with the primary antibody at a dilution of 1/20. A goat anti rabbit IgG (Alexa Fluor® 488) at a dilution of 1/2000 was used as the secondary antibody.
Isoytype control : Rabbit monoclonal IgG (Black)
Unlabeled control : Cell without incubation with primary antibody and secondary antibody (Blue)
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
Immunocytochemical analysis of MCF7 (human breast adenocarcinoma cell line) cells, labeling Cdk4 with purified ab108357 at 1/100. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500), was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. ab7291, a mouse anti-tubulin (1/1000) and ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500) were also used.
Control 1 : primary antibody (1/100) and secondary antibody, ab150120, an Alexa Fluor® 594-conjugated goat anti-mouse IgG (1/500).
Control 2 : ab7291 (1/1000) and secondary antibody, ab150077, an Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/500).
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
Intracellular Flow Cytometry analysis of MCF7 (human breast adenocarcinoma cell line) cells labelling Cdk4 with purified ab108357 at 1/40 (red). Cells were fixed with 2% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/150) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
Immunohistochemical analysis of formalin/PFA-fixed paraffin-embedded human urothelial carcinoma tissue labelling Cdk4 with unpurified ab108357 at a dilution of 1/100.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
ab108357 staining Cdk4 in wild-type HAP1 cells (top panel) and Cdk4 knockout HAP1 cells (bottom panel). The cells were fixed with 4% formaldehyde (10min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab108357 at 1/500 dilution and ab195889 at 1/250 dilution (shown in pseudo colour red) overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to Rabbit IgG (Alexa Fluor® 488) (ab150081) at 2 μg/ml (shown in green). Nuclear DNA was labelled in blue with DAPI.
- WB
Unknown
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
Lanes 5 and 6 : Merged signal (red and green). Green - ab108357 observed at 34kDa. Red - loading control to beta actin observed at 40kDa.
ab108357 was shown to specifically react with CDK4 in wild-type HAP1 cells. No band was observed when CDK4 knockout samples were examined. Wild-type and CDK4 knockout samples were subjected to SDS-PAGE. ab108357 and ab8226 (loading control to beta actin) were both diluted at 1/1000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
Lanes 1 - 4:
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (ab108357) at 1/1000 dilution
Lanes 5 - 6:
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (ab108357)
Lanes 1, 3 and 5:
Wild-type HAP1 cell lysate at 20 µg
Lanes 2, 4 and 6:
CDK4 knockout HAP1 cell lysate at 20 µg
Predicted band size: 34 kDa
false
- WB
Lab
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
Lanes 1- 2 : Merged signal (red and green). Green - ab108357 observed at 34 kDa. Red - Anti-Vinculin antibody [VIN-54] observed at 124 kDa.
ab108357 was shown to react with Cdk4 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab255378 (knockout cell lysate ab263780) was used. Wild-type HeLa and CDK4 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab108357 and Anti-Vinculin antibody [VIN-54] overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (ab108357) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
CDK4 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human CDK4 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cdk4-knockout-hela-cell-line-ab255378'>ab255378</a>)
Predicted band size: 34 kDa,55 kDa
Observed band size: 34 kDa,55 kDa
false
- WB
AbReview45217****
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
All lanes:
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (ab108357) at 1/1000 dilution
Lane 1:
Human osteosarcoma whole cell lysate - control, non-targeting siRNA at 20 µg
Lane 2:
Human osteosarcoma whole cell lysate - siRNA for CDK4 at 20 µg
Secondary
All lanes:
HRP-conjugated goat anti-rabbit IgG polyclonal at 1/2000 dilution
Predicted band size: 34 kDa
Observed band size: 34 kDa
true
Exposure time: 5s
This image is courtesy of an Abreview submitted by Sonia Rocha
- WB
Lab
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
Blocking and dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Cdk4 antibody [EPR4513-32-7] (ab108357) at 1/10000 dilution
Lane 1:
HeLa (human epithelial cell line from cervix adenocarcinoma) cell lysate at 20 µg
Lane 2:
K562 (human chronic myelogenous leukemia cell line from bone marrow) cell lysate at 20 µg
Lane 3:
Ramos (human Burkitt's lymphoma cell line) cell lysate at 20 µg
Secondary
All lanes:
Peroxidase-conjugated goat anti-rabbit IgG, (H+L) at 1/1000 dilution
Predicted band size: 34 kDa
Observed band size: 34 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-Cdk4 antibody [EPR4513-32-7] (AB108357)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (5)
-
Anti-Cdk4 antibody [EPR4513-32-7] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cdk4 antibody [EPR4513-32-7]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cdk4 antibody [EPR4513-32-7]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cdk4 antibody [EPR4513-32-7]
-
HRP Anti-Cdk4 antibody [EPR4513-32-7]
Reactivity data
Product details
What is this antibody validated in?
Anti-Cdk4 antibody [EPR4513-32-7] (ab108357) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.
What is the molecular weight of Cdk4?
Anti-Cdk4 [EPR4513-32-7] (ab108357) specifically detects a band for Cdk4 (UniProt: P11802) at a molecular weight of 34kDa.
Trusted by the scientific community
Anti-Cdk4 [EPR4513-32-7] (ab108357) was first used in a scientific publication in 2011 and has been cited over 160 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-Cdk4 antibody [EPR4513-32-7] (ab108357) has been confirmed by Western blot testing in CDK4 Knockout HAP1 cells.
Other related products
We have a range of other formats of antibody clone [EPR4513-32-7] also available for your convenience: ab108357, Alexa Fluor® 488 - ab193966, Alexa Fluor® 647 - ab193967, HRP - ab193968, Carrier free - ab213216, Alexa Fluor® 555 - ab215318
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Cdk4 plays a fundamental role in cell cycle regulation by forming a complex with D-type cyclins. Together they phosphorylate the retinoblastoma protein (Rb) resulting in the release of E2F transcription factors which promote the expression of genes necessary for DNA replication. The Cdk4/cyclin D complex regulates the cell's commitment to enter S phase and continue cell division. This regulation is key for normal cell proliferation and tissue homeostasis. Cdk4 activity is strictly controlled by INK4 family members acting as inhibitors and adding an extra regulation layer.
Pathways
Cdk4 is an integral part of important signaling pathways like the cell cycle and PI3K/AKT pathways. In the cell cycle pathway Cdk4 relays signals downstream that drive the transition from the G1 to S phase through its interaction with cyclin D and Rb. In the PI3K/AKT pathway signaling can influence cyclin D expression indirectly affecting Cdk4 activity. Proteins such as Cdk6 closely relate to Cdk4 and often compensate or partner with Cdk4 in these pathways to maintain proper cell cycle progression.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (216)
Recent publications for all applications. Explore the full list and refine your search
OncoTargets and therapy 18:979-994 PubMed40934061
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational lung cancer research 14:2771-2787 PubMed40799432
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:28579 PubMed40764324
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC gastroenterology 25:365 PubMed40360974
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 25:666 PubMed40217155
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 44:112 PubMed40181456
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer 24:29 PubMed39856701
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:1787 PubMed39805936
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology research 33:123-132 PubMed39735672
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 24:397 PubMed39639311
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com